Vyvanse for Adult ADHD: How It Works, Side Effects, and What to Expect
Short answer: Vyvanse is the brand name for lisdexamfetamine, a once-daily prescription stimulant approved to treat attention-deficit/hyperactivity disorder, or ADHD, in adults. The body converts lisdexamfetamine into dextroamphetamine, which can reduce inattention, impulsivity, and hyperactivity. Vyvanse can be effective for some adults, but it is not appropriate for everyone and carries important cardiovascular, psychiatric, dependence, misuse, and overdose risks.
Many adults search for Vyvanse because they are struggling with distractibility, procrastination, disorganization, time blindness, impulsive decisions, or inconsistent performance. These problems can occur with ADHD, but they can also be caused or worsened by anxiety, depression, trauma, poor sleep, substance use, medical conditions, and medication effects.
That is why responsible ADHD treatment begins with a comprehensive evaluation, not a guaranteed prescription.
What is Vyvanse?
Vyvanse is a central nervous system stimulant containing lisdexamfetamine dimesylate. It is FDA-approved to treat ADHD in adults and patients six years and older. It is also approved to treat moderate to severe binge-eating disorder in adults, but it is not approved or recommended as a weight-loss medication.
Lisdexamfetamine is a prodrug of dextroamphetamine. A prodrug is a medication that must be converted by the body into its active form. After Vyvanse is absorbed, the body converts lisdexamfetamine into dextroamphetamine, an amphetamine stimulant. This conversion process makes Vyvanse pharmacologically different from medications that contain active amphetamine as soon as they are taken.
The exact way stimulants improve ADHD is not fully understood. Amphetamines affect dopamine and norepinephrine signaling, which is involved in attention, motivation, alertness, working memory, and impulse control. This does not mean that ADHD is simply a chemical deficiency or that everyone with ADHD will respond to the same medication.
The National Institute of Mental Health identifies medication and psychosocial interventions, including cognitive behavioral therapy, as standard ADHD treatments. Medication may reduce symptoms, while behavioral treatment helps adults build planning systems, routines, and skills that medication cannot create by itself.
What symptoms can Vyvanse help?
When Vyvanse is effective and well tolerated, an adult may notice improvement in areas such as:
Sustaining attention during routine or demanding tasks
Starting and completing tasks with fewer detours
Resisting distractions
Pausing before acting or speaking
Organizing work and following a sequence
Holding information in working memory
Managing internal or physical restlessness
Following through more consistently
The goal is not to feel euphoric, unusually energized, emotionally numb, or intensely focused on the wrong activity. A useful response is usually practical: important tasks become easier to begin, manage, and complete.
Medication should improve real-world functioning, not merely create a sensation of focus. Treatment decisions should consider work, home, relationships, driving, finances, self-care, sleep, and overall quality of life.
How does Vyvanse work?
Vyvanse is absorbed as lisdexamfetamine and converted into dextroamphetamine. The active dextroamphetamine affects dopamine and norepinephrine activity in the central nervous system. Unlike Adderall XR, which uses a formulation designed to release active mixed amphetamine salts in stages, Vyvanse relies on conversion of its prodrug into active medication.
Being a prodrug does not make Vyvanse risk-free, non-addictive, or impossible to misuse. Vyvanse remains an amphetamine medication with an FDA boxed warning for abuse, misuse, and addiction.
How long does Vyvanse last?
Vyvanse is designed for once-daily treatment and is generally taken in the morning. In an FDA-reviewed simulated workplace study of adults with ADHD, improvement in attention was measured at assessment points from two through 14 hours after a morning dose. That does not mean every adult will receive exactly 14 hours of benefit.
Onset and duration can vary based on the individual, dose, symptom pattern, sleep, other medications, and the outcome being measured. Some adults notice that Vyvanse begins helping later than an immediate-release stimulant. Others find that it wears off earlier or later than expected.
During a medication trial, it helps to track:
What time benefit begins
Which ADHD symptoms improve
Whether actual functioning improves
What time benefit fades
Appetite and weight changes
Sleep onset and sleep quality
Anxiety, irritability, or mood changes
Blood pressure and heart rate when requested
Any late-day return or rebound of symptoms
This information is more useful than simply reporting that the medication felt strong, weak, good, or bad.
How is Vyvanse taken?
Vyvanse is generally taken once each morning, with or without food. Afternoon dosing is avoided because it may interfere with sleep. It is available as capsules and chewable tablets.
According to the current FDA prescribing information for Vyvanse, a capsule may be swallowed whole or opened and mixed with water, orange juice, or yogurt. The entire mixture should be consumed immediately and should not be stored. Chewable tablets should be chewed thoroughly. A single capsule or chewable tablet should not be divided into smaller doses.
Follow the directions on your own prescription. Do not alter the dose, divide a dose, or use another person’s medication.
What is a typical Vyvanse dosage for adults with ADHD?
The FDA-labeled starting dosage for adult ADHD is 30 mg once daily in the morning. The label permits adjustment in 10 mg or 20 mg increments at approximately weekly intervals, with a recommended range of 30 mg to 70 mg once daily and a maximum recommended dosage of 70 mg per day.
These numbers describe the FDA labeling, not a personalized recommendation. The right dose is the lowest dose that produces meaningful improvement with acceptable side effects. Some adults need a slower titration, a different formulation, a different stimulant class, or a non-stimulant. Kidney impairment and medication interactions can also affect dosing limits and decisions.
Never increase Vyvanse because it feels weaker than expected or does not last as long as another person’s medication. Review the symptom pattern, duration, side effects, sleep, food intake, and other variables with the prescriber.
What are the common side effects of Vyvanse in adults?
In a four-week clinical trial of adults with ADHD included in the FDA labeling, decreased appetite and insomnia were each reported by 27% of Vyvanse-treated participants, and dry mouth was reported by 26%. Other reported effects included diarrhea, nausea, anxiety, feeling jittery, agitation, increased blood pressure, sweating, restlessness, weight loss, shortness of breath, increased heart rate, tremor, and palpitations.
Common or clinically important side effects can include:
Decreased appetite
Trouble sleeping
Dry mouth
Nausea or diarrhea
Anxiety or feeling jittery
Irritability or agitation
Increased heart rate or blood pressure
Sweating
Weight loss
Restlessness or tremor
Side effects may be influenced by dose, timing, caffeine, sleep, hydration, nutrition, and other medications. Contact the prescriber if an effect is persistent, distressing, or interfering with eating, sleeping, mood, or daily life. Do not adjust the dose on your own.
What are the serious risks of Vyvanse?
Cardiovascular effects
Vyvanse can increase blood pressure and heart rate. Before treatment, a clinician should review blood pressure, cardiac symptoms, relevant medical history, family history, and other risk factors. The FDA label advises avoiding Vyvanse in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease.
Seek urgent medical care for chest pain, fainting, severe shortness of breath, or other symptoms that may indicate a heart problem.
Psychiatric effects
Amphetamine medications can worsen pre-existing psychosis and may trigger new psychotic or manic symptoms in susceptible people. A careful evaluation should review current and past depression, bipolar symptoms, psychosis, anxiety, trauma, suicidality, substance use, and relevant family history.
Contact a clinician promptly for hallucinations, paranoia, severe agitation, marked mood elevation, or a major and unusual change in behavior. Use emergency services when symptoms create immediate danger.
Circulation problems
Stimulants can cause peripheral vasculopathy, including Raynaud’s phenomenon. Tell the prescriber about new numbness, pain, coldness, sensitivity, or color changes in the fingers or toes.
Serotonin syndrome and medication interactions
Vyvanse can interact with serotonergic medications and other drugs. Serotonin syndrome is uncommon but potentially life-threatening. Symptoms can include agitation, confusion, fever, sweating, rapid heart rate, unstable blood pressure, tremor, muscle rigidity, overactive reflexes, vomiting, or diarrhea.
Vyvanse is contraindicated while taking a monoamine oxidase inhibitor, or within 14 days after stopping one, because of the risk of hypertensive crisis. Give the prescriber and pharmacist a complete list of prescriptions, over-the-counter medications, vitamins, and supplements.
Misuse, addiction, dependence, and overdose
Vyvanse is a Schedule II controlled substance. It has accepted medical uses but also a high potential for abuse and dependence. The FDA requires prescription stimulants to carry prominent warnings about misuse, abuse, addiction, overdose, and death.
Take Vyvanse exactly as prescribed, never share it, store it securely, and dispose of unused medication properly. Physical dependence and tolerance can occur with prolonged use even when a stimulant is taken as directed. Abrupt discontinuation or a large dose reduction after prolonged use can produce fatigue, low mood, sleep changes, increased appetite, and agitation. Discuss medication changes with the prescriber.
Vyvanse vs. Adderall: what is the difference?
Vyvanse and Adderall are both amphetamine stimulants used to treat ADHD, but they are not the same medication. Vyvanse contains lisdexamfetamine, which the body converts into dextroamphetamine, and it is designed for once-daily use. Adderall contains a mixture of active dextroamphetamine and levoamphetamine salts and is available in immediate-release and extended-release formulations. Vyvanse may provide a longer treatment window than Adderall IR, while its duration may overlap with other long-acting stimulants such as Adderall XR.
Neither medication is universally stronger, safer, smoother, or better. The best choice depends on symptom coverage, side effects, medical history, psychiatric history, sleep, appetite, cost, availability, and previous response. The prodrug design of Vyvanse does not eliminate its misuse, dependence, or overdose risks.
Is generic Vyvanse available?
Yes. The FDA approved the first generic versions of Vyvanse in 2023. Generic lisdexamfetamine is available in capsule and chewable-tablet forms.
Brand and generic products must meet FDA standards, but pharmacy inventory, insurance coverage, out-of-pocket cost, and an individual’s experience may vary. Ask the pharmacist or insurer which formulation and manufacturer are available. Do not switch the dose or dosage form without confirmation from the prescriber and pharmacist.
Does feeling calmer on Vyvanse prove that you have ADHD?
No. A person’s reaction to Vyvanse does not confirm or rule out ADHD. People with ADHD may describe feeling calmer, less mentally scattered, or more able to direct their attention. However, stimulants can also increase attention and alertness in people who do not have ADHD.
ADHD is diagnosed from a persistent pattern of symptoms, evidence that symptoms began during the developmental period, functional impairment in more than one area of life, and consideration of other explanations. If you are unsure whether your difficulties fit ADHD, review the most common ADHD symptoms in adults and seek a comprehensive evaluation rather than using medication response as a test.
What should an adult ADHD evaluation include before Vyvanse is prescribed?
A careful adult ADHD evaluation should assess more than current distractibility. It may include:
Childhood and adolescent symptoms
Current inattention, hyperactivity, and impulsivity
Functional impairment at work, school, home, and in relationships
Sleep quality and possible sleep disorders
Anxiety, depression, trauma, bipolar symptoms, and substance use
Medical and cardiovascular history
Current medications and previous treatment response
Validated ADHD rating scales
Collateral information or computerized testing when appropriate
No single questionnaire, computer test, or medication response can diagnose ADHD by itself. The purpose of the evaluation is to determine whether ADHD best explains the pattern and which treatment options are appropriate and safe.
What if Vyvanse is not the right medication?
Vyvanse is only one ADHD treatment option. Depending on the diagnosis, health history, medication response, and treatment goals, alternatives may include:
A different amphetamine formulation
A methylphenidate-based stimulant
A non-stimulant ADHD medication
Cognitive behavioral therapy or executive-function coaching
Sleep, exercise, nutrition, environmental, and organizational interventions
Treatment of another condition contributing to attention problems
If Vyvanse causes side effects, begins working too late, wears off too early, is difficult to obtain, or does not improve meaningful functioning, the answer is not always a higher dose. Review 19 Adderall alternatives that may improve focus for an overview of other stimulant, non-stimulant, and non-medication options.
Vyvanse treatment for adults in New Hampshire and Massachusetts
Six States ADHD provides comprehensive adult ADHD evaluations and individualized medication management for adults in New Hampshire and Massachusetts. New patients begin with an in-person evaluation in Salem, New Hampshire, or Boston, Massachusetts. Follow-up visits may be completed by telehealth when clinically appropriate.
Medication is prescribed only when clinically appropriate after diagnostic and safety review. Scheduling an evaluation does not guarantee a Vyvanse prescription. Treatment may involve Vyvanse, another stimulant, a non-stimulant, behavioral strategies, or a different plan based on the findings.
Learn more about adult ADHD treatment in New Hampshire, adult ADHD treatment in Massachusetts, or how to get an ADHD medication prescription through a proper evaluation.
Frequently asked questions about Vyvanse
What is Vyvanse used for?
Vyvanse is FDA-approved to treat ADHD in adults and patients six years and older. It is also approved for moderate to severe binge-eating disorder in adults. It is not approved or recommended for weight loss.
Is Vyvanse an amphetamine?
Yes. Vyvanse contains lisdexamfetamine, a prodrug that the body converts into dextroamphetamine. It is a central nervous system stimulant and a Schedule II controlled substance.
Is Vyvanse the same as Adderall?
No. Vyvanse is lisdexamfetamine, which the body converts into dextroamphetamine. Adderall contains active mixed amphetamine salts and is available in immediate-release and extended-release forms.
How long does Vyvanse last in adults?
Vyvanse is designed for once-daily treatment. An adult workplace study assessed benefit through 14 hours after a morning dose, but individual onset, duration, and symptom coverage vary.
What is the usual Vyvanse dosage for adults with ADHD?
The FDA-labeled starting dosage is 30 mg once daily in the morning. The labeled recommended range is 30 mg to 70 mg once daily, with a maximum recommended dosage of 70 mg per day. Individual dosing must be determined by the prescriber.
Can a Vyvanse capsule be opened?
The FDA label permits a Vyvanse capsule to be opened and the entire contents mixed with water, orange juice, or yogurt, then consumed immediately. The mixture should not be stored, and a single dose should not be divided.
Is generic Vyvanse available?
Yes. FDA-approved generic lisdexamfetamine capsules and chewable tablets became available after the first approvals in 2023. Pharmacy inventory and insurance coverage vary.
Is Vyvanse addictive when taken as prescribed?
Vyvanse can be used safely by appropriately selected and monitored patients, but prescribed use still carries risks of misuse, addiction, physical dependence, and tolerance. Take it only as prescribed, do not share it, and store it securely.
Can Vyvanse be used for weight loss?
Vyvanse is not approved or recommended for weight loss or obesity. It is approved for ADHD and for moderate to severe binge-eating disorder in adults. Appetite suppression or weight loss as a side effect does not make it a weight-loss medication.
Can I get a Vyvanse prescription online in New Hampshire or Massachusetts?
Controlled-substance prescribing depends on current federal and state requirements as well as the clinician’s policies and judgment. At Six States ADHD, new adult patients begin with an in-person comprehensive evaluation in Salem, NH, or Boston, MA. Follow-ups may be available by telehealth when clinically appropriate. No specific medication is guaranteed.
Schedule an adult ADHD evaluation
If you live in New Hampshire or Massachusetts and are wondering whether Vyvanse or another ADHD treatment may be appropriate, Six States ADHD can help you move from guessing to a structured plan.
Schedule a free phone consultation or adult ADHD evaluation.
Six States ADHD specializes in adults 18 and older, with in-person evaluation locations in Salem, NH, and Boston, MA, and telehealth follow-up options for eligible patients located in New Hampshire or Massachusetts.
Medical disclaimer: This article is for general educational purposes and is not a diagnosis, prescription, or substitute for individualized medical care. Do not start, stop, share, or change the dose of Vyvanse or another prescription medication without guidance from your treating clinician. Seek emergency help for severe or life-threatening symptoms.